Cargando…
A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes
Kallmann syndrome is the result of innate genetic defects in the fibroblast growth factor (FGF) regulated signaling network causing diminished signal transduction. One of the rare mutations associated with the syndrome alters the Sprouty (Spry)4 protein by converting the serine at position 241 into...
Autores principales: | Stütz, Astrid, Kamptner, Anna Z. M., Sutterlüty, Hedwig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926442/ https://www.ncbi.nlm.nih.gov/pubmed/33670044 http://dx.doi.org/10.3390/ijms22042145 |
Ejemplares similares
-
Sprouty3, but Not Sprouty1, Expression Is Beneficial for the Malignant Potential of Osteosarcoma Cells
por: Kamptner, Anna Zita Mehira, et al.
Publicado: (2021) -
Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells
por: Celik-Selvi, Burcu Emine, et al.
Publicado: (2019) -
Cosuppression of Sprouty and Sprouty-Related Negative Regulators of FGF Signalling in Prostate Cancer: A Working Hypothesis
por: Assinder, Stephen J., et al.
Publicado: (2015) -
Seminal Plasma Lipidomics Profiling to Identify Signatures of Kallmann Syndrome
por: Li, Xiaogang, et al.
Publicado: (2021) -
Inducing Sprouty degradation
por: LeBrasseur, Nicole
Publicado: (2003)